MiNK Therapeutics's total assets for Q3 2025 were $14.96M, an increase of 502.30% from the previous quarter. INKT total liabilities were $28.48M for the fiscal quarter, a 2.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.